CPMG Inc, Director, 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 221,652 shares at $59.90 ($13.2M) on 2018-12-12, disclosed to the SEC on 2018-12-12.
Open-market purchase of $13.2M RETA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.93 | 26,174 | $1.5M | 11.5% |
| 2 | $57.93 | 26,174 | $1.5M | 11.5% |
| 3 | $58.62 | 1,078 | $63K | 0.5% |
| 4 | $58.62 | 1,078 | $63K | 0.5% |
| 5 | $59.53 | 29,347 | $1.7M | 13.3% |
| 6 | $59.53 | 29,347 |
| $1.7M |
| 13.3% |
| 7 | $60.07 | 52,809 | $3.2M | 24.1% |
| 8 | $60.07 | 52,809 | $3.2M | 24.1% |
| 9 | $59.90 | 1,418 | $85K | 0.6% |
| 10 | $59.90 | 1,418 | $85K | 0.6% |
| Total | $59.41 avg | 221,652 | $13.2M | 100% |
| Filing → |
| RETA | BUY | 2019-11-18 | $7.4M | — | Filing → |
| RETA | BUY | 2017-12-29 | $484K | — | Filing → |
| RETA | BUY | 2017-12-28 | $1.7M | — | Filing → |